VU6067416
![]()  | |
| Identifiers | |
|---|---|
IUPAC name 
  | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C12H12BrN3 | 
| Molar mass | 278.153 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
VU6067416 is an indazole derivative which acts as an agonist for the 5-HT2 family of serotonin receptors. It is a potent full agonist at 5-HT2B, and has slightly lower affinity and partial agonist effects at 5-HT2A and 5-HT2C,[1] though some related compounds have improved selectivity for 5-HT2A.[2]
See also
References
- ↑ Jayakodiarachchi N, Maurer MA, Schultz DC, Dodd CJ, Thompson Gray A, Cho HP, et al. (January 2024). "Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists". ACS Medicinal Chemistry Letters. doi:10.1021/acsmedchemlett.3c00566. PMC 10860182.
 - ↑ Kargbo RB (November 2023). "Small-Molecule Heterocyclic Compounds: Gq-Biased Agonists for the 5-HT2A Receptor in Neuropsychiatric Treatment". ACS Medicinal Chemistry Letters. 14 (11): 1498–1500. doi:10.1021/acsmedchemlett.3c00444. PMID 37974947.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
